The Food and Drug Administration exempted Evoke Pharma Inc.'s (Nasdaq: EVOK) Gimoti from a Human Factors Validation study requirement sending the stock price soaring 79 cents to close at $3.40.
FDA exempts Evoke Pharma's Gimoti
February 15, 2017 at 18:56 PM EST
